Dirk Jäger

21.3k total citations · 9 hit papers
220 papers, 11.8k citations indexed

About

Dirk Jäger is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Dirk Jäger has authored 220 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Oncology, 57 papers in Immunology and 56 papers in Molecular Biology. Recurrent topics in Dirk Jäger's work include Immunotherapy and Immune Responses (44 papers), Pancreatic and Hepatic Oncology Research (42 papers) and Cancer Immunotherapy and Biomarkers (36 papers). Dirk Jäger is often cited by papers focused on Immunotherapy and Immune Responses (44 papers), Pancreatic and Hepatic Oncology Research (42 papers) and Cancer Immunotherapy and Biomarkers (36 papers). Dirk Jäger collaborates with scholars based in Germany, United States and Switzerland. Dirk Jäger's co-authors include Markus W. Büchler, Oliver Strobel, Alexander Knuth, John P. Neoptolemos, Niels Halama, Jürgen Debus, Elke Jäger, Christoph Springfeld, Thilo Hackert and Julia Karbach and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Dirk Jäger

211 papers receiving 11.7k citations

Hit Papers

68Ga-FAPI PET/CT: Tracer ... 1998 2026 2007 2016 2019 2013 2019 2018 2019 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dirk Jäger 6.8k 3.4k 2.9k 2.2k 2.1k 220 11.8k
Caj Haglund 4.6k 0.7× 1.2k 0.3× 3.9k 1.3× 2.4k 1.1× 1.1k 0.5× 363 11.5k
Julien Caldéraro 3.3k 0.5× 1.5k 0.4× 3.2k 1.1× 2.4k 1.1× 933 0.4× 164 10.2k
Albrecht Stenzinger 6.9k 1.0× 1.4k 0.4× 3.8k 1.3× 4.1k 1.9× 1.3k 0.6× 368 13.5k
Sunil Badve 6.4k 0.9× 1.3k 0.4× 5.5k 1.9× 4.6k 2.1× 897 0.4× 309 14.3k
Klaus J. Busam 16.6k 2.4× 4.2k 1.3× 9.3k 3.2× 2.7k 1.3× 1.3k 0.6× 426 24.8k
Natale Cascinelli 8.2k 1.2× 2.8k 0.8× 2.8k 1.0× 3.5k 1.6× 939 0.4× 123 12.1k
C. Blake Gilks 4.6k 0.7× 1.6k 0.5× 4.6k 1.6× 3.0k 1.4× 681 0.3× 291 16.7k
Barbara Burtness 8.5k 1.2× 2.0k 0.6× 4.4k 1.5× 2.4k 1.1× 1.4k 0.6× 363 16.0k
Alistair J. Cochran 12.0k 1.8× 3.7k 1.1× 4.8k 1.7× 2.8k 1.3× 575 0.3× 182 16.6k
Chuong D. Hoang 4.6k 0.7× 3.9k 1.2× 5.5k 1.9× 3.5k 1.6× 1.0k 0.5× 101 13.1k

Countries citing papers authored by Dirk Jäger

Since Specialization
Citations

This map shows the geographic impact of Dirk Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Jäger more than expected).

Fields of papers citing papers by Dirk Jäger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Jäger. The network helps show where Dirk Jäger may publish in the future.

Co-authorship network of co-authors of Dirk Jäger

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Jäger. A scholar is included among the top collaborators of Dirk Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Jäger. Dirk Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberti, María Paula, Pornpimol Charoentong, Stefan B. Eichmüller, et al.. (2025). Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site. OncoImmunology. 14(1). 2457793–2457793. 1 indexed citations
3.
Tosev, Georgi, Adam Kaczorowski, Constantin Schwab, et al.. (2024). PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study. Diagnostics. 14(7). 741–741.
4.
Ferber, Dyke, Isabella C. Wiest, Georg Wölflein, et al.. (2024). GPT-4 for Information Retrieval and Comparison of Medical Oncology Guidelines. NEJM AI. 1(6). 47 indexed citations breakdown →
5.
Klotz, Rosa, Nathalia A. Giese, Thilo Hackert, et al.. (2023). Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Cancers. 15(6). 1815–1815. 8 indexed citations
6.
Schütz, Viktoria, Huancai Lin, Adam Kaczorowski, et al.. (2023). Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma. Cancers. 15(24). 5715–5715. 2 indexed citations
7.
Schneider, F, Adam Kaczorowski, Martina Kirchner, et al.. (2023). Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma. Cancers. 15(20). 5050–5050. 6 indexed citations
8.
Leber, Mathias F., Sascha Bossow, Christine E. Engeland, et al.. (2021). MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer. Molecular Therapy — Oncolytics. 21. 340–355. 14 indexed citations
9.
Krauß, Jürgen, Dirk Jäger, Stefanie Zschäbitz, et al.. (2021). eHealth intervention to manage symptoms for patients with cancer on immunotherapy (SOFIA): a study protocol for a randomised controlled external pilot trial. BMJ Open. 11(7). e047277–e047277. 6 indexed citations
10.
Becker, Jürgen C., Annette Paschen, Dirk Jäger, et al.. (2021). Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells. Life. 11(4). 269–269. 10 indexed citations
11.
Leber, Mathias F., Christine E. Engeland, Sascha Bossow, et al.. (2020). Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations. Journal of General Virology. 101(4). 399–409. 5 indexed citations
12.
Nientiedt, Cathleen, Anette Duensing, Stefanie Zschäbitz, et al.. (2020). PARP inhibition in prostate cancer. Genes Chromosomes and Cancer. 60(5). 344–351. 6 indexed citations
13.
Bailey, Peter J., Daniel Hübschmann, Anne Berger, et al.. (2020). Poly(ADP‐ribose) polymerase inhibition in pancreatic cancer. Genes Chromosomes and Cancer. 60(5). 373–384. 15 indexed citations
14.
Weber, Tim Frederik, Oliver Sedlaczek, Georg Martin Haag, et al.. (2020). Improving radiologic communication in oncology: a single-centre experience with structured reporting for cancer patients. Insights into Imaging. 11(1). 106–106. 10 indexed citations
15.
Berger, Anne, Sadaf S. Mughal, Michael Allgäuer, et al.. (2020). Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease. Pancreatology. 20(3). 425–432. 17 indexed citations
16.
Kather, Jakob Nikolas, Johannes Krisam, Pornpimol Charoentong, et al.. (2019). Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study. PLoS Medicine. 16(1). e1002730–e1002730. 611 indexed citations breakdown →
17.
Muckenhuber, Alexander, Anne Berger, Anna Melissa Schlitter, et al.. (2017). Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response. Clinical Cancer Research. 24(2). 351–359. 61 indexed citations
18.
Kather, Jakob Nikolas, Jan Poleszczuk, Meggy Suarez‐Carmona, et al.. (2017). In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer. Cancer Research. 77(22). 6442–6452. 79 indexed citations
19.
Theurillat, Jean‐Philippe, Ursina Zürrer‐Härdi, Zsuzsanna Varga, et al.. (2007). NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunology Immunotherapy. 56(11). 1723–1731. 38 indexed citations
20.
Jäger, Elke, Julia Karbach, Sacha Gnjatic, et al.. (2002). Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. PubMed. 2. 12–12. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026